Hervé Mittre, Christian Marcelli, Michel Leporrier. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antibodies, Monoclonal/administration & dosageArthritis, Rheumatoid/drug therapyDose-Response Relationship, DrugDrug Administration ScheduleFollow-Up StudiesFusion Proteins, bcr-abl/geneticsHumansInfliximabInjections, IntravenousLeukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosisLeukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapyMaleMethotrexate/administration & dosageMiddle AgedNeoplasm, Residual/diagnosisNeoplasm, Residual/drug therapyReverse Transcriptase Polymerase Chain Reaction/methodsTreatment Outcome
Substances： See more » Antibodies, MonoclonalInfliximabFusion Proteins, bcr-ablMethotrexate
Year: 2006 PMID： 16740308 DOI： 10.1016/j.leukres.2006.03.023
Source DB: PubMed Journal: Leuk Res ISSN： 0145-2126 Impact factor: 3.156